Jagomäe, T., Seppa, K., Reimets, R., Pastak, M., Plaas, M., Hickey, M. A., . . . Plaas, M. (2021). Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype. MDPI AG.
Cita Chicago Style (17a ed.)Jagomäe, Toomas, et al. Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype. MDPI AG, 2021.
Cita MLA (8a ed.)Jagomäe, Toomas, et al. Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype. MDPI AG, 2021.